Doctors have detected that the viral strain is showing "different behaviour", though it will only be conclusive once research is conducted on the make up of the virus.
"Dengue and chikungunya both are caused by the same aedes mosquito but dengue can be contracted through four viral strains while chikungunya is caused only by one strain.
"Also, in dengue cases, some strains are more virulent than other ones. The number of rising cases of chikungunya this year after the 2006 spike could be due to an evolution in its strain," National Vector Borne Disease Control Programme (NVBDCP) Director A C Dhariwal said.
"People in north India haven't been really exposed to the chikungunya strain compared to the population in the southern part of the country, and therefore they are more vulnerable to this viral attack," Municipal Health Officer of SDMC, P K Hazarika told PTI.
He, however, said the probability of evolution of the viral strain will just be a speculation until scientists establish it.
IgM-ELISA and Reverse Transcription-Polymerase Chain Reaction (RT-PCR) are the two main tests used to detect chikungunya in patients.
"We used IgM serology on patients earlier but then after finding discrepancy between clinical diagnosis and laboratory tests, we started performing molecular test (RT-PCR) to detect the chikungunya virus from the blood of clinically suspected patients from September 1 onwards," the doctor said.
"And from Sep 1-13, out of 565 samples of suspected viral fever, 319 came positive for chikungunya virus which is about 56 per cent positivity. So, we found out that a test coming negative by IgM is coming positive by RT-PCR. And, this could mean the number of cases in Delhi could be much higher than currently reported," he said.
According to the Bangalore-based doctor, "The prevalence of arbovirus infections similar to chikungunya virus in south India especially in states like Karnataka, Tamil Nadu have made people tolerant to these infections."
The number of chikungunya cases in the national capital have climbed to over 1,700 this season and at least 12 deaths have been reported due to the disease.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
